FDA NDC Directory · JSON-LD · Markdown

Ocrevus Zunovo

NDC 50242-554 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameocrelizumab and hyaluronidase
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761371
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (23000 U/23mL)
OCRELIZUMAB (920 mg/23mL)
Marketing started20240913
Package count2

External sources

Source: openFDA. Public-domain (CC0).